Development of Cyclopeptide Inhibitors Specifically Disrupting FXR-coactivator Interaction in the Intestine As a Novel Therapeutic Strategy for MASH.
Life metabolism（2025）
Key words
intestine-targeted drugs,FXR antagonists,cyclopeptide,metabolic dysfunction-associated steatohepatitis,protein-protein interactions
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined